-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Aptevo Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
- Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$5.1M, a 19.5% increase year-over-year.
- Aptevo Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$23.7M, a 46.9% decline year-over-year.
- Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$17.4M, a 317% decline from 2022.
- Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $8.03M.
- Aptevo Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.5M, a 60.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)